Contact
      Please use this form to send email to PR contact of this press release:
      
      Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Leiomyoma, Date of authorisation: 16/07/2021, Revision: 6, Status: Authorised
    
      TO: